Antiangiogenic Therapy With Bevacizumab in Retinopathy of Prematurity. Structural Outcome

Clinical trial NCT00346814 · UNKNOWN

Trial details

NCT number: NCT00346814
Sponsor: Asociación para Evitar la Ceguera en México
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Retinopathy of Prematurity

Start date: 2007-07-01
Primary completion: 2007-07-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.